These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11121564)

  • 1. A model for hepatocarcinogenesis with clonal expansion of three successive phenotypes of preneoplastic cells.
    Geisler I; Kopp-Schneider A
    Math Biosci; 2000 Dec; 168(2):167-85. PubMed ID: 11121564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incorporating phenotype-dependent growth rates into the color-shift model for preneoplastic hepatocellular lesions.
    Burkholder I; Kopp-Schneider A
    Math Biosci; 2002; 179(2):145-60. PubMed ID: 12208613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A model for hepatocarcinogenesis treating phenotypical changes in focal hepatocellular lesions as epigenetic events.
    Kopp-Schneider A; Portier C; Bannasch P
    Math Biosci; 1998 Mar; 148(2):181-204. PubMed ID: 9610106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular pathology of early stage chemically induced hepatocarcinogenesis.
    Ogawa K
    Pathol Int; 2009 Sep; 59(9):605-22. PubMed ID: 19712128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of a color-shift model with heterogeneous growth to a rat hepatocarcinogenesis experiment.
    Groos J; Kopp-Schneider A
    Math Biosci; 2006 Aug; 202(2):248-68. PubMed ID: 16603206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analysis of changes in cell proliferation and apoptosis during preneoplastic and neoplastic stages of hepatocarcinogenesis in rat.
    Kong J; Ringer DP
    Cancer Lett; 1996 Aug; 105(2):241-8. PubMed ID: 8697450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of multiple cell cycle aberrations in early preneoplastic liver cell lesions by tumor promotion with thioacetamide in a two-stage rat hepatocarcinogenesis model.
    Kimura M; Fujii Y; Yamamoto R; Yafune A; Hayashi SM; Suzuki K; Shibutani M
    Exp Toxicol Pathol; 2013 Nov; 65(7-8):979-88. PubMed ID: 23474136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xenomorphic hepatocellular precursors and neoplastic progression of tigroid cell foci induced in rats with low doses of N-nitrosomorpholine.
    Ströbel P; Klimek F; Zerban H; Kopp-Schneider A; Bannasch P
    Carcinogenesis; 1998 Dec; 19(12):2069-80. PubMed ID: 9886559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose and time dependence of the cellular phenotype in rat hepatic preneoplasia and neoplasia induced in stop experiments by oral exposure to N-nitrosomorpholine.
    Weber E; Bannasch P
    Carcinogenesis; 1994 Jun; 15(6):1227-34. PubMed ID: 8020160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose and time dependence of the cellular phenotype in rat hepatic preneoplasia and neoplasia induced by single oral exposures to N-nitrosomorpholine.
    Weber E; Bannasch P
    Carcinogenesis; 1994 Jun; 15(6):1219-26. PubMed ID: 8020159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vanadium inhibits the development of 2-acetylaminofluorene-induced premalignant phenotype in a two-stage chemical rat hepatocarcinogenesis model.
    Chakraborty T; Chatterjee A; Saralaya MG; Dhachinamoorthi D; Chatterjee M
    Life Sci; 2006 May; 78(24):2839-51. PubMed ID: 16352317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of NNM-induced carcinogenesis in the rat liver by phenobarbital: a combined morphological and enzyme histochemical approach.
    Moore MA; Hacker HJ; Kunz HW; Bannasch P
    Carcinogenesis; 1983; 4(4):473-9. PubMed ID: 6132686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of somatic mutations and cell replication kinetics in quantitative cancer risk assessment.
    Moolgavkar SH; Luebeck EG
    Prog Clin Biol Res; 1991; 369():469-79. PubMed ID: 1835095
    [No Abstract]   [Full Text] [Related]  

  • 14. Lack of p53 protein expression in preneoplastic rat hepatocytes in vitro after exposure to N-acetoxy-acetylaminofluorene, X-rays or a proteasome inhibitor.
    van Gijssel HE; Stenius U; Mulder GJ; Meerman JH
    Eur J Cancer; 2000 Jan; 36(1):106-12. PubMed ID: 10741303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stochastic analysis of intermediate lesions in carcinogenesis experiments.
    Luebeck EG; Moolgavkar SH
    Risk Anal; 1991 Mar; 11(1):149-57. PubMed ID: 1828119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sequential cellular and molecular changes during hepatocarcinogenesis].
    Bannasch P
    Verh Dtsch Ges Pathol; 1995; 79():72-83. PubMed ID: 8600697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative analysis of enzyme-altered foci in rat hepatocarcinogenesis experiments--I. Single agent regimen.
    Moolgavkar SH; Luebeck EG; de Gunst M; Port RE; Schwarz M
    Carcinogenesis; 1990 Aug; 11(8):1271-8. PubMed ID: 2143703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two stage model for carcinogenesis: number and size distributions of premalignant clones in longitudinal studies.
    Dewanji A; Goddard MJ; Krewski D; Moolgavkar SH
    Math Biosci; 1999 Jan; 155(1):1-12. PubMed ID: 10024832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoplastic progression in experimental hepatocarcinogenesis.
    Scherer E
    Biochim Biophys Acta; 1984; 738(4):219-36. PubMed ID: 6394049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell proliferation and apoptosis in normal liver and preneoplastic foci.
    Schulte-Hermann R; Bursch W; Kraupp-Grasl B; Oberhammer F; Wagner A; Jirtle R
    Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):87-90. PubMed ID: 8013429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.